MCET (MultiCell Technologies) Total Equity: $-1.62 Mil (As of Aug. 2015)


What is MultiCell Technologies Total Equity?

MultiCell Technologies MCET -90.00% Total Equity is $-1.62 Mil as of Aug. 2015.

MultiCell Technologies's total equity for the quarter that ended in Aug. 2015 was $-1.62 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

MultiCell Technologies Total Equity Historical Data

* Premium members only.

The historical data trend for MultiCell Technologies's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MultiCell Technologies Total Equity Chart

MultiCell Technologies Annual Data
Trend Nov05 Nov06 Nov07 Nov08 Nov09 Nov10 Nov11 Nov12 Nov13 Nov14
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.02 -1.75 -1.62 -1.57 -1.52

MultiCell Technologies Quarterly Data
Nov10 Feb11 May11 Aug11 Nov11 Feb12 May12 Aug12 Nov12 Feb13 May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.64 -1.52 -1.72 -1.45 -1.62

MultiCell Technologies Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

MultiCell Technologies's Total Equity for the fiscal year that ended in Nov. 2014 is calculated as

Total Equity=Total Assets(Q: Nov. 2014 )-Total Liabilities(Q: Nov. 2014 )
=0.126-1.643
=-1.52

MultiCell Technologies's Total Equity for the quarter that ended in Aug. 2015 is calculated as

Total Equity=Total Assets(Q: Aug. 2015 )-Total Liabilities(Q: Aug. 2015 )
=0.296-1.917
=-1.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $-1.62 Mil mean?
MultiCell Technologies (MCET) has a Total Equity of $-1.62 Mil as of Aug. 2015. The total amount of equity as record on a company's balance sheet. View historical data for MultiCell Technologies and its competitors.
Is MultiCell Technologies' Total Equity too high?
MultiCell Technologies' current Total Equity is $-1.62 Mil.
How does MultiCell Technologies' Total Equity compare to ERGO and OPLI?
MultiCell Technologies' Total Equity of $-1.62 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for MultiCell Technologies and its competitors. MultiCell Technologies's current Total Equity is $-1.62 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MultiCell Technologies stock overvalued right now?
MultiCell Technologies (MCET) has a current Total Equity of $-1.62 Mil. The current Total Equity is $-1.62 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For MultiCell Technologies (MCET), the current Total Equity is $-1.62 Mil as of Aug. 2015. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MultiCell Technologies Business Description

Address 4144 North Central Expressway, Suite 600, Dallas, TX, USA, 75204
MultiCell Technologies Inc is a biopharmaceutical company. It is engaged in developing novel therapeutics and discovery tools for the treatment of neurological disorders, hepatic disease, cancer, and others. Its therapeutic development platform includes several patented techniques used to isolate, characterize, and differentiate stem cells from the human liver or control the immune response at transcriptional and translational levels through dsRNA-sensing molecules, such as Toll-like receptor, RIG-I-like receptor, and MDA-5 signaling. The company's medical device development platform is based on the design of a next-generation bioabsorbable stent, the Ideal BioStent, for interventional cardiology and peripheral vessel applications. All the operations are functioned within United States.